Store in a cool, dry place, out of reach of children
GLP-1 initiation was driven primarily by nurse practitioners (28.0%), family medicine providers (22.4%), endocrinologists (16.3%), internal medicine providers (11.1%), and physician assistants (10.3%), while OB/GYN providers accounted for 5.5%
Not a prescription-free GLP-1
Clinical trial data from Eli Lillys Phase 2 study showed that the 12mg weekly dose produced an average weight loss of 24.2% over 48 weeks, with over 80% of participants losing at least 15% of their starting body weight
Bu et al
Heres our process: every peptide therapy patient begins with comprehensive bloodwork, including baseline IGF-1 levels (our primary biomarker for GH status), a complete metabolic panel, thyroid function, and sex hormones